Unknown

Dataset Information

0

Targeting HER2 beyond breast cancer.


ABSTRACT: The structural basis of blocking human epidermal growth factor receptor-2 (HER2) dimerization remains of great interest to generate effective anti-cancer therapies. Despite clinically feasible outcome in mammary tumors, a fine consensus between efficacy and safety remains a critical challenge beyond breast cancer. Here we extrapolate on the balancing act using recently reported clinical findings in salivary ductal carcinomas.

SUBMITTER: Bhatnagar S 

PROVIDER: S-EPMC6512921 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting HER2 beyond breast cancer.

Bhatnagar Sanchita S   Tushir-Singh Jogender J  

Molecular & cellular oncology 20190320 3


The structural basis of blocking human epidermal growth factor receptor-2 (HER2) dimerization remains of great interest to generate effective anti-cancer therapies. Despite clinically feasible outcome in mammary tumors, a fine consensus between efficacy and safety remains a critical challenge beyond breast cancer. Here we extrapolate on the balancing act using recently reported clinical findings in salivary ductal carcinomas. ...[more]

Similar Datasets

| S-EPMC10478787 | biostudies-literature
| S-EPMC7768135 | biostudies-literature
| S-EPMC10210145 | biostudies-literature
| S-EPMC3660991 | biostudies-literature
| S-EPMC6397550 | biostudies-literature
| S-EPMC6429068 | biostudies-literature
| S-EPMC3251862 | biostudies-literature
| S-EPMC5674043 | biostudies-literature
| S-EPMC8230691 | biostudies-literature
| S-EPMC9122332 | biostudies-literature